📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular Diseases. (2021)

First Author: Servais L

Attributed to: Oxford P2D: From Technologies to Therapies funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1159/000517411

PubMed Identifier: 34723071

Publication URI: http://europepmc.org/abstract/MED/34723071

Type: Journal Article/Review

Volume: 5

Parent Publication: Digital biomarkers

Issue: 2

ISSN: 2504-110X